{'fraction_non_alphanumeric': 0.03176470588235294, 'fraction_numerical': 0.004705882352941176, 'mean_word_length': 5.303703703703704, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
In Vivo Reversal of Amyloid‐β Lesions in Rat Brain

Cerebral amyloid-β (Aβ) deposition is central to the neuropathological definition of Alzheimer disease (AD) with Aβ related toxicity being linked to its β-sheet conformation and/or aggregation. We show that a β-sheet breaker peptide (iAβ5) dose-dependently and reproducibly induced in vivo disassembly of fibrillar amyloid deposits, with control peptides having no effect. The iAβ5-induced disassembly prevented and/or reversed neuronal shrinkage caused by Aβ and reduced the extent of interleukin-1β positive microglia-like cells that surround the Aβ deposits. These findings suggest that β-sheet breakers, such as iAβ5 or similar peptidomimetic compounds, may be useful for reducing the size and/or number of cerebral amyloid plaques in AD, and subsequently diminishing Aβ-related histopathology.